Review



senescence marker  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Bioss senescence marker
    Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of <t>senescence</t> marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.
    Senescence Marker, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc12838251-1-2-5?v=Bioss
    Average 91 stars, based on 27 article reviews
    senescence marker - by Bioz Stars, 2026-07
    91/100 stars

    Images

    1) Product Images from "Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement"

    Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

    Journal: Biology

    doi: 10.3390/biology15020187

    Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of senescence marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.
    Figure Legend Snippet: Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of senescence marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.

    Techniques Used: Immunofluorescence, Staining, Marker

    Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.
    Figure Legend Snippet: Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

    Techniques Used: Immunofluorescence, Staining



    Similar Products

    91
    Bioss senescence marker
    Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of <t>senescence</t> marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.
    Senescence Marker, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc12838251-1-2-5?v=Bioss
    Average 91 stars, based on 1 article reviews
    senescence marker - by Bioz Stars, 2026-07
    91/100 stars
      Buy from Supplier

    94
    Proteintech anti senescence marker protein 30
    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence <t>marker</t> <t>protein‐30</t> <t>(SMP30),</t> Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
    Anti Senescence Marker Protein 30, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc12793064-65-26-32?v=Proteintech
    Average 94 stars, based on 1 article reviews
    anti senescence marker protein 30 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc primary antibodies against cell senescence marker p16
    Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Primary Antibodies Against Cell Senescence Marker P16, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc12485397-59-0-11?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    primary antibodies against cell senescence marker p16 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    95
    Eppendorf AG senescence markers expression
    Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Senescence Markers Expression, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc12309371__gkaf706_supplemental_file-202-22-28?v=Eppendorf+AG
    Average 95 stars, based on 1 article reviews
    senescence markers expression - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc p21 waf1 cip1 contained in senescence marker antibody sampler kit catalog 56062
    Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    P21 Waf1 Cip1 Contained In Senescence Marker Antibody Sampler Kit Catalog 56062, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc12284356-76-29-43?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    p21 waf1 cip1 contained in senescence marker antibody sampler kit catalog 56062 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc antibodies against cell senescence marker p16
    Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Antibodies Against Cell Senescence Marker P16, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/10__1016_slash_j__jds__2025__07__017-72-2-12?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    antibodies against cell senescence marker p16 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc senescence marker antibody sampler kit
    Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Senescence Marker Antibody Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/10__1016_slash_j__jhepr__2025__101488-105-28-38?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    senescence marker antibody sampler kit - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    86
    Proteostasis Therapeutics senescence markers in cryopreserved frbcs
    Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Senescence Markers In Cryopreserved Frbcs, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pm40400214-3577-11-9?v=Proteostasis+Therapeutics
    Average 86 stars, based on 1 article reviews
    senescence markers in cryopreserved frbcs - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc mouse reactive senescence marker antibody sampler kit cell signaling technology 78551 phospho histone h2a x
    Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Mouse Reactive Senescence Marker Antibody Sampler Kit Cell Signaling Technology 78551 Phospho Histone H2a X, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/bio_rxiv__2025__03__28__645957-168-36-43?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    mouse reactive senescence marker antibody sampler kit cell signaling technology 78551 phospho histone h2a x - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc mouse reactive senescence marker antibody sampler kit
    Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell <t>senescence</t> triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker <t>p16</t> was determined by Western blot under the same treatment conditions (B).
    Mouse Reactive Senescence Marker Antibody Sampler Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/senescence+marker/pmc11848672__jitc___13___2___s001-44-40-47?v=Cell+Signaling+Technology+Inc
    Average 93 stars, based on 1 article reviews
    mouse reactive senescence marker antibody sampler kit - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of senescence marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.

    Journal: Biology

    Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

    doi: 10.3390/biology15020187

    Figure Lengend Snippet: Presence and distribution of senescent cells during OTM. ( A ) Representative p21 and p16 immunofluorescence staining images with DAPI. ( B ) Quantitative analysis of p21 + area in PDL. ( C ) Quantitative analysis of p16 + area in PDL. ( D , E ) Distribution of senescence marker–positive areas in the 60 g and 180 g groups. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). * p < 0.05; *** p < 0.001; **** p < 0.0001; one-way ANOVA with Tukey’s test. PDL: periodontal ligament, AB: alveolar bone.

    Article Snippet: p21 , Senescence marker , Bioss Antibodies (Shanghai, China) , bs-10129R , AF555 , 1:100.

    Techniques: Immunofluorescence, Staining, Marker

    Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

    Journal: Biology

    Article Title: Force-Dependent Presence of Senescent Cells Expressing Vascular Endothelial Growth Factor During Orthodontic Tooth Movement

    doi: 10.3390/biology15020187

    Figure Lengend Snippet: Cellular senescence of vascular endothelial cells (ECs) induced by OTM. ( A ) Representative p21 and CD31 immunofluorescence staining images. p21/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( B ) Quantitative analysis of p21 + CD31 + area in PDL. ( C ) Representative p16 and CD31 immunofluorescence staining images. p16/CD31 staining without DAPI ( left ) and merged images with DAPI ( right ) are shown. ( D ) Quantitative analysis of p16 + CD31 + area in PDL. Scale bars: 100 µm (low magnification), 10 µm (high magnification). Data are mean ± SD (n = 4). ns: not significant, * p < 0.05; ** p < 0.01; Kruskal–Wallis with Dunn’s post hoc test. PDL: periodontal ligament, AB: alveolar bone.

    Article Snippet: p21 , Senescence marker , Bioss Antibodies (Shanghai, China) , bs-10129R , AF555 , 1:100.

    Techniques: Immunofluorescence, Staining

    Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Journal: Aging Cell

    Article Title: NMNAT1 Activates Autophagy to Delay D‐Galactose‐Induced Aging in Cochlear Hair Cells

    doi: 10.1111/acel.70373

    Figure Lengend Snippet: Establishment of D‐gal‐treated aging model in HEI‐OC1 cells. (A) Schematic illustration of D‐gal treatment in HEI‐OC1 cells. (B) Cell viability after exposure to different concentrations of D‐gal, evaluated using the CCK‐8 assay ( n = 4, independent samples). (C) Immunofluorescent staining of Mito‐SOX in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (D) Quantitative analysis of Mito‐SOX intensity in C ( n = 4, independent samples). (E) Mito‐SOX levels were detected using flow cytometry in HEI‐OC1 cells exposed to D‐gal (5 and 20 mg/mL) for 72 h. (F) Statistical analysis of Mito‐SOX levels in E ( n = 3, independent samples). (G) Immunofluorescent staining of DCFH‐DA in HEI‐OC1 cells. (H) Quantitative analysis of DCFH‐DA intensity in G ( n = 4, independent samples). (I) DCFH‐DA levels were detected using flow cytometry in HEI‐OC1 cells. (J) Statistical analysis of DCFH‐DA levels in I ( n = 3, independent samples). (K–M) Western blot analysis of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X in HEI‐OC1 cells treated with D‐gal. (N–P) Statistical analysis of SMP30 ( n = 4, independent samples), Lamin B1 ( n = 3, independent samples), and γ‐H2A.X ( n = 3, independent samples) expression in K–M. Scale bar: 20 μm. Statistical significance as ns, no significant difference, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Article Snippet: The primary antibodies used in this study were as follows: rabbit anti‐β‐tubulin (1:40000, 5568; CST), rabbit anti‐β‐Actin (1:40000, 20536‐1‐AP; Proteintech), mouse anti‐GAPDH (1:4000, ab8245; Abcam), rabbit anti‐senescence marker protein‐30 (SMP30) (1:1000, 17947‐1‐AP; Proteintech), rabbit anti‐lamin B1 (1:1000, 13435; CST), rabbit anti‐γ‐H2A.X (1:400, 2577; CST), rabbit anti‐P21 (1:1000, 37543; CST), rabbit anti‐P16 (1:1000, 29271; CST), rabbit anti‐NMNAT1 (1:1000, 98354; CST), rabbit anti‐NMNAT1 (1:400, 11399‐1‐AP; Proteintech), rabbit anti‐LC3B (1:1000, 3868; CST), rabbit anti‐P62 (1:1000, 23214; CST), mouse anti‐autophagy related 7 (ATG7) (1:1000, 67341; Proteintech), and rabbit anti‐BECLIN1 (1:1000, 3495; CST).

    Techniques: CCK-8 Assay, Staining, Flow Cytometry, Western Blot, Marker, Expressing

    Establishment of D‐gal‐induced aging model in cochlear explants. (A) Immunofluorescence staining demonstrating the number of myosin7a + hair cells in cochlear explants treated with 20, 30, and 40 mg/mL D‐gal for 72 h. (B) Quantification of the number of myosin7a + hair cells in cochlear explants ( n = 4; four individual explants from four mice). (C–E) Western blotting of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X expression in cochlear explants exposed to D‐gal. (F–H) Statistical analysis of SMP30 ( n = 5), Lamin B1 ( n = 3), and γ‐H2A.X ( n = 3) in C–E; n corresponds to the number of independent samples, each consisting of 12 explants from six mice. (I) Senescence‐associated β‐gal staining images of hair cells in cochlear explants exposed to D‐gal. (J) Quantification of β‐gal staining intensity in I ( n = 4; four individual explants from four mice). Scale bar: 20 μm. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Journal: Aging Cell

    Article Title: NMNAT1 Activates Autophagy to Delay D‐Galactose‐Induced Aging in Cochlear Hair Cells

    doi: 10.1111/acel.70373

    Figure Lengend Snippet: Establishment of D‐gal‐induced aging model in cochlear explants. (A) Immunofluorescence staining demonstrating the number of myosin7a + hair cells in cochlear explants treated with 20, 30, and 40 mg/mL D‐gal for 72 h. (B) Quantification of the number of myosin7a + hair cells in cochlear explants ( n = 4; four individual explants from four mice). (C–E) Western blotting of senescence marker protein‐30 (SMP30), Lamin B1, and γ‐H2A.X expression in cochlear explants exposed to D‐gal. (F–H) Statistical analysis of SMP30 ( n = 5), Lamin B1 ( n = 3), and γ‐H2A.X ( n = 3) in C–E; n corresponds to the number of independent samples, each consisting of 12 explants from six mice. (I) Senescence‐associated β‐gal staining images of hair cells in cochlear explants exposed to D‐gal. (J) Quantification of β‐gal staining intensity in I ( n = 4; four individual explants from four mice). Scale bar: 20 μm. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Article Snippet: The primary antibodies used in this study were as follows: rabbit anti‐β‐tubulin (1:40000, 5568; CST), rabbit anti‐β‐Actin (1:40000, 20536‐1‐AP; Proteintech), mouse anti‐GAPDH (1:4000, ab8245; Abcam), rabbit anti‐senescence marker protein‐30 (SMP30) (1:1000, 17947‐1‐AP; Proteintech), rabbit anti‐lamin B1 (1:1000, 13435; CST), rabbit anti‐γ‐H2A.X (1:400, 2577; CST), rabbit anti‐P21 (1:1000, 37543; CST), rabbit anti‐P16 (1:1000, 29271; CST), rabbit anti‐NMNAT1 (1:1000, 98354; CST), rabbit anti‐NMNAT1 (1:400, 11399‐1‐AP; Proteintech), rabbit anti‐LC3B (1:1000, 3868; CST), rabbit anti‐P62 (1:1000, 23214; CST), mouse anti‐autophagy related 7 (ATG7) (1:1000, 67341; Proteintech), and rabbit anti‐BECLIN1 (1:1000, 3495; CST).

    Techniques: Immunofluorescence, Staining, Western Blot, Marker, Expressing

    Flammulina velutipes polysaccharides (FVP) attenuated cell senescence triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker p16 was determined by Western blot under the same treatment conditions (B).

    Journal: Journal of Dental Sciences

    Article Title: Flammulina velutipes polysaccharides exhibit potent antioxidant and anti-pyroptotic properties in diabetes-associated periodontitis: A preliminary in vitro study

    doi: 10.1016/j.jds.2025.07.017

    Figure Lengend Snippet: Flammulina velutipes polysaccharides (FVP) attenuated cell senescence triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker p16 was determined by Western blot under the same treatment conditions (B).

    Article Snippet: Primary antibodies against cell senescence marker p16 and pyroptosis markers ASC (Cell Signaling Inc., Danvers, MA, USA), NLRP3 (Invitrogen Life Technologies, Carlsbad, CA, USA), pro-caspase-1 and cleaved caspase-1 (Abcam, Cambridge, UK), pro-GSDMD and cleaved GSDMD (Cell signaling), pro-IL-1β and IL-1β (Cell signaling), and GAPDH (Invitrogen) were used.

    Techniques: Activity Assay, Marker, Western Blot

    Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell senescence triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker p16 was determined by Western blot under the same treatment conditions (B).

    Journal: Journal of Dental Sciences

    Article Title: Flammulina velutipes polysaccharides exhibit potent antioxidant and anti-pyroptotic properties in diabetes-associated periodontitis: A preliminary in vitro study

    doi: 10.1016/j.jds.2025.07.017

    Figure Lengend Snippet: Figure 3 Flammulina velutipes polysaccharides (FVP) attenuated cell senescence triggered by advanced glycation end products (AGEs) and lipopolysaccharide (LPS)-treated human gingival fibroblasts (HGFs). Senescence-associated β-galactosidase (SA-β-gal) activity was measured in HGFs pretreated with AGEs and LPS, followed by the addition of FVP (A). The protein level of senescence marker p16 was determined by Western blot under the same treatment conditions (B).

    Article Snippet: 27 Primary antibodies against cell senescence marker p16 and pyroptosis markers ASC (Cell Signaling Inc., Danvers, MA, USA), NLRP3 (Invitrogen Life Technologies, Carlsbad, CA, USA), pro-caspase-1 and cleaved caspase-1 (Abcam, Cambridge, UK), pro-GSDMD and cleaved GSDMD (Cell signaling), pro-IL-1β and IL-1β (Cell signaling), and GAPDH (Invitrogen) were used.

    Techniques: Activity Assay, Marker, Western Blot